The Legacy of Dr. Rita Levi-Montalcini: Advances in Neurotrophic Factors in Brain Disease Development and Treatment Volume II

  • 321

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 11 April 2026

  2. This Research Topic is currently accepting articles.

Background

Given the success of The Legacy of Dr. Rita Levi-Montalcini: Advances in Neurotrophic Factors in Brain Disease Development and Treatment, we are pleased to announce the launch of Volume II.

Given the success of the The Legacy of Dr. Rita Levi-Montalcini: Advances in Neurotrophic Factors in Brain Disease Development and Treatment we are pleased to announce the launch of Volume II.

Dr. Rita Levi-Montalcini (1909-2012) is one of the most prominent scientists and formidable figures in neuroscience. In 1986 she received a Nobel Prize Award, together with her colleague Stanley Cohen, recognizing the groundbreaking discovery of nerve growth factor. This fundamental understanding of mechanisms regulating cell growth and maintenance, revolutionized our understanding of the nervous system development and differentiation. Dr. Levi-Montalcini’s impressive academic career spanned over five decades of investigating neurotrophic factors that had immeasurable effects on multiple scientific fields. Later in life, she focused on advocating for scientists across the world to have access to adequate funding, equipment, and support. During her political career, which started in 2001 with an appointment as Senator of Life in the Italian senate, Dr. Levi-Montalcini famously leveraged her deciding vote over the new budget to reverse planned cuts to scientific funding.

The road to Dr. Levi-Montalcini’s scientific breakthroughs, especially early on in her career, took a place against a backdrop of various forms of oppression, the Jewish persecution during World War II, and challenges associated with an ardent feminist stance. The adversities, which later in life she acknowledged contributed to her drive, tenacity, and ultimately achieving the Nobel Prize Award. After graduating from University of Turin, she remained there for a short time as a research assistant, but in 1938 she lost the post as the Italian government introduced discriminatory laws forbidding Jews to hold academic positions. This did not stop her from pursuing answers to her scientific questions as she set up a makeshift laboratory in her bedroom, using everyday utensils as tools to study motor neurons in chicken embryos. As the German invasion and shelling of Turin intensified, in 1943 her family fled to Florence where they survived Holocaust under false identities and returned to Turin 2 years later. Shortly after their return, she was offered a position at Washington University by a Professor who was interested in two of her early articles. She then remained at Washington University for the next 30 years, where she reproduced some of the experiments conducted in her bedroom leading to the isolation of the nerve growth factor in 1952 and from there, her academic career flourished.

This Research Topic aims to highlight and build on Dr. Levi-Montalcini’s legacy of the nerve growth factor discovery and extensive research career on this subject matter. The goal is to spotlight recent advances and methods in neurotrophic factors in brain disease development and treatment.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Data Report
  • Editorial
  • FAIR² Data
  • FAIR² DATA Direct Submission
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: neurotrophic factors, nervous system development, differentiation, brain disease, nerve growth factor

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 321Topic views
View impact